Matthew Q. Schmidt

Matthew Q. Schmidt

Auto-generated profile, based on publicly available information

Matthew Q. Schmidt

Department of Internal Medicine, Saint Joseph Hospital, Denver, CO

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Oral Oncology
Verified
Journal Article
Closed access
MSMatthew Q. Schmidt
Matthew Q. Schmidt
JDJohn David
John David
EYEmi J. Yoshida
Emi J. Yoshida
KSKevin Scher
Kevin Scher
AMAlain Mita
Alain Mita
ZZZachary S. Zumsteg
Zachary S. Zumsteg

1 July 2018 in Advances in Radiation Oncology
Verified
Journal Article
Open access
CVCarlos E Vargas
Carlos E Vargas
MSMatthew Q. Schmidt
Matthew Q. Schmidt
JNJoshua R. Niska
Joshua R. Niska
WHWilliam F. Hartsell
William F. Hartsell
SKSameer R. Keole
Sameer R. Keole
GLGary L. Larson
Gary L. Larson
Randomized evidence for extreme hypofractionation in prostate cancer is lacking. We aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and extreme hypofractionated radiation in a phase 3 randomized trial. We analyzed the results of the first 75 patients in our phase 3 trial, comparing 38 Gy relative biologic effectiveness (RBE) in 5 fractions (n = 46) versus 79.2 Gy RBE in 44 fractions (n = 29). Patients received proton radiation using fiducials and daily image guidance. We evaluated American Urological Association Symptom Index (AUASI), adverse events (AEs), and Expanded Prostate Index Composite (EPIC) domains. The primary endpoint of this interim analysis was the cumulative incidence of grade 2 (G2) or higher AEs. The randomized patient allocation scheme was a 2:1 ratio favoring the 38 Gy RBE arm. The median follow-up was 36 months; 30% of patients reached 48-month follow-up. AUASI scores differed <5 points (4.4 vs 8.6; P = .002) at 1 year, favoring the 79.2 Gy arm. Differences in AUASI were not significant at ≥18 months. EPIC urinary symptoms favored the 79.2 Gy arm at 1 year (92.3 vs 84.5; P = .009) and 18 months (92.3 vs 85.3; P = .03); bother scores were not significant at other time points. Cumulative ≥G2 genitourinary toxicity was similar between the 79.2 Gy and 38 Gy arms (34.5% vs 30.4%; P = .80). We found no differences in the EPIC domains of bowel symptoms, sexual symptoms, or bowel ≥G2 toxicities. Bladder V80 (79.2 Gy arm; P = .04) and V39 (38 Gy arm; P = .05) were predictive for cumulative G2 genitourinary AEs. Low AE rates were seen in both study arms. Early temporary differences in genitourinary scores disappeared over time. Bladder constraints were associated with genitourinary AEs.

28 September 2019 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
AMAjay Major
Ajay Major
AHAndrew Hammes
Andrew Hammes
MSMatthew Q. Schmidt
Matthew Q. Schmidt
RMRustain Morgan
Rustain Morgan
DADiana Abbott
Diana Abbott
MKManali Kamdar
Manali Kamdar

1 July 2019 in World Journal of Nuclear Medicine
Verified
Journal Article
Open access
MSMatthew Q Schmidt
Matthew Q Schmidt
ZTZachary Trenbeath
Zachary Trenbeath
Bennett ChinBennett Chin
Bennett Chin
The importance of gallium-68 DOTA-Tyr3-octreotate (68Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known metastatic NET who underwent 68Ga DOTATATE PET/CT for restaging, incidentally revealing intense uptake of the prostate with a maximum standard uptake value of 17.4. Due to the patient's medical history, this finding was concerning for neuroendocrine prostate cancer. However, core biopsies of the prostate were negative for malignancy and positive for chronic inflammation. Chronic prostatitis is a very common condition in adult males and is often asymptomatic. Inflammatory conditions, including prostatitis, are important causes of false-positive findings on 68Ga DOTATATE PET/CT and should be considered as part of the differential diagnosis, even in an asymptomatic patient.

1 December 2017 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
MSMatthew Q. Schmidt
Matthew Q. Schmidt
FSFrank V. Schraml
Frank V. Schraml
A 55-year old woman presented in an obtunded state and was found to have a subarachnoid hemorrhage. After endovascular repair, her condition deteriorated, and brain death was suspected. A 99mTc bicisate brain blood flow study was performed, which showed a complete absence of blood flow to the cerebellum despite intact circulation to the cerebral hemispheres. These atypical findings are likely a result of a transient intracranial pressure differential and the timing of the study. A timely and accurate declaration of brain death has important psychosocial and ethical implications, particularly when organ donation is being considered.

1 April 2016 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MKManraj S. Khosla
Manraj S. Khosla
MSMatthew Q. Schmidt
Matthew Q. Schmidt
SWSachin Wani
Sachin Wani
ADAnanya Das
Ananya Das